Related Experiment Video
Updated: May 9, 2026
07:18
High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
Mathematical models of viral latency.
Christian Selinger1, Michael G Katze
1Department of Microbiology, University of Washington, Box 358070, Seattle, WA 98195-8070, USA.
Current Opinion in Virology
|July 31, 2013
Summary
Mathematical models explore antiviral therapy challenges, predicting viral rebound from latent reservoirs. Current models are reductionist, overlooking cell diversity and epigenetic factors impacting HIV latency dynamics.
Area of Science:
- Virology
- Mathematical Biology
- Immunology
Background:
- Viral latency presents a significant challenge for effective antiviral therapies.
- Mathematical modeling offers a dynamical systems approach to understand disease progression and latent viral reservoirs.
- Predicting long-term viral eradication from short-term data remains difficult.
Purpose of the Study:
- To review and assess differential equation models used in predicting antiviral therapy outcomes.
- To evaluate the success of these models in guiding clinicians and predicting viral rebound.
- To identify limitations in current mathematical models of HIV latency.
Main Methods:
- Review of differential equation models for viral dynamics.
- Assessment of model predictive power for viral eradication and rebound.
- Analysis of model limitations concerning cellular heterogeneity and host factors.
Main Results:
- Many models predict a substantial risk of viral rebound due to continuous reseeding of latent reservoirs.
- Models often underestimate the complexity of HIV latency.
- Current models are criticized for being reductionist.
Conclusions:
- Mathematical models provide insights into viral dynamics but have limitations in predicting long-term outcomes.
- The complexity of HIV latency, including diverse cell types and epigenetic modifications, needs to be incorporated into future models.
- Improved models are crucial for guiding clinical decisions and achieving viral eradication.
Related Concept Videos
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:15Pharmacodynamic Models: Logarithmic Concentration–Effect Model
The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...